Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pragmatic, Multicentre, Parallel-Group, Superiority Randomised Controlled Trial Comparing Threshold-Based Versus Guideline-Recommended Range-Based Aerobic Exercise Prescription for Improving Cardiorespiratory Fitness in Patients Undergoing Cardiac Rehabilitation

NCT07908810 is registered in ClinicalTrials.gov with Hasselt University as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07908810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
A Pragmatic, Multicentre, Parallel-Group, Superiority Randomised Controlled Trial Comparing Threshold-Based Versus Guideline-Recommended Range-Based Aerobic Exercise Prescription for Improving Cardiorespiratory Fitness in Patients Undergoing Cardiac Rehabilitation
Lead sponsor
Hasselt University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
April 30, 2027
Completion date
March 31, 2030
Enrollment
230 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac rehabilitation, cardiovascular diseases

Arms

As registered; 2 arms.

  • Threshold-Based Exercise Prescription ExperimentalThreshold-Based Aerobic Exercise Intensity Prescription

    Participants allocated to this group will receive an individualised aerobic exercise prescription based on the first and second ventilatory thresholds (VT1 and VT2) determined during cardiopulmonary exercise testing (CPET). Exercise intensity will be prescribed using heart rate boundaries corresponding to these physiological thresholds. Participants will follow a 15-week supervised cardiac rehabilitation programme, targeting 40 exercise sessions, with centrally generated prescriptions and standardised progression principles.

  • Range-Based Exercise Prescription Active comparatorRange-Based Aerobic Exercise Intensity Prescription

    Participants allocated to this group will receive an individualised aerobic exercise prescription based on the guideline-recommended range of 40-69% of heart rate reserve (HRR), calculated using resting and peak heart rates obtained during CPET. Participants will follow the same 15-week supervised cardiac rehabilitation programme, targeting 40 exercise sessions, with centrally generated prescriptions and standardised progression principles.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Change in Peak Oxygen Uptake (VO2peak) From Baseline to 4 Months Baseline and 4 months (±1 week)

    The primary outcome is the change in peak oxygen uptake (VO2peak), expressed in mL/kg/min, from baseline to 4 months.

    VO2peak will be measured using symptom-limited cardiopulmonary exercise testing (CPET) according to standardised procedures. Change will be calculated as the 4-month value minus the baseline value. The primary comparison will assess the between-group difference in mean change in VO2peak.

Lead sponsor's other trials

Hasselt University, most recent start first.

Similar trials

Same condition (Cardiovascular Diseases) and phase, most recent start first.